These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 26696201)
1. [Clinical efficacy and safety of rush immunotherapy in patients with allergic rhinitis]. Xie W; Zhang H; Chen J; Wang Y Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):641-5. PubMed ID: 26696201 [TBL] [Abstract][Full Text] [Related]
2. Immunologic alterations and efficacy of subcutaneous immunotherapy with Dermatophagoides pteronyssinus in monosensitized and polysensitized patients. Soyyigit S; Guloglu D; Ikinciogullari A; Secil D; Oztuna D; Mungan D; Misirligil Z; Sin BA Ann Allergy Asthma Immunol; 2016 Mar; 116(3):244-251.e2. PubMed ID: 26945497 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis]. Huang HH; Xu C; Liu L; Chai RN Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859 [No Abstract] [Full Text] [Related]
4. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis]. Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066 [No Abstract] [Full Text] [Related]
5. Responsiveness of Nasal Provocation Testing-But Not Skin Test and Specific Immunoglobulin E Blood Level-Correlates With Severity of Allergic Rhinitis in Dermatophagoides Species-Sensitized Patients. Wanjun W; Qiurong H; Yanqing X; Mo X; Nili W; Jing L Am J Rhinol Allergy; 2018 Jul; 32(4):236-243. PubMed ID: 29909644 [TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432 [TBL] [Abstract][Full Text] [Related]
7. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy. Liu Y; Xing Z; Wang J; Geng C Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065 [TBL] [Abstract][Full Text] [Related]
8. The Importance of Nasal Provocation Testing in the Diagnosis of Xiao H; Jia Q; Zhang H; Zhang L; Liu G; Meng J Am J Rhinol Allergy; 2022 Mar; 36(2):191-197. PubMed ID: 34388048 [TBL] [Abstract][Full Text] [Related]
9. Correlation of skin test results and specific immunoglobulin E blood levels with nasal provocation testing for house-dust mite allergies. Haxel BR; Huppertz T; Boessert P; Bast F; Fruth K Am J Rhinol Allergy; 2016; 30(1):60-4. PubMed ID: 26867532 [TBL] [Abstract][Full Text] [Related]
10. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens. Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116 [TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of two commercial house dust mite extracts for allergic rhinitis: a head-to-head study. Li J; Wu Y; Yang Y; Huang N; Li W; Zhang S; Jiang Q; Yang L; Zhu R Int Forum Allergy Rhinol; 2019 Aug; 9(8):876-882. PubMed ID: 31322838 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of the efficacy and compliance of conventional immunotherapy and rush immunotherapy in patients with allergic rhinitis]. Zhu ZC; Qiu QH; Chen Z; Huang HM; Han H; Chen JJ; Kong WJ Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(2):81-86. PubMed ID: 29757549 [No Abstract] [Full Text] [Related]
13. [Nasal provocation tests with house dust mite in patients with perennial rhinitis]. Damps I; Mincewicz G; Poławska K; Kurowski W; Stankiewicz C; Słomiński JM Otolaryngol Pol; 2003; 57(1):69-74. PubMed ID: 12741147 [TBL] [Abstract][Full Text] [Related]
14. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma]. Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933 [TBL] [Abstract][Full Text] [Related]
15. House-dust mite nasal provocation: a diagnostic tool in perennial rhinitis. Chusakul S; Phannaso C; Sangsarsri S; Aeumjaturapat S; Snidvongs K Am J Rhinol Allergy; 2010; 24(2):133-6. PubMed ID: 20338112 [TBL] [Abstract][Full Text] [Related]
16. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis. Bozek A; Ignasiak B; Filipowska B; Jarzab J Clin Exp Allergy; 2013 Feb; 43(2):242-8. PubMed ID: 23331565 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Sublingual Immunotherapy with Dermatophagoides farinae Extract in Monosensitized and Polysensitized Patients with Allergic Rhinitis: Clinical Observation and Analysis. Xu CX; Zhang ML; Li BZ; He Y; Zou ZH; Wu QR; Tao AL; Lai H; Sun JL Biomed Res Int; 2015; 2015():187620. PubMed ID: 26000283 [TBL] [Abstract][Full Text] [Related]
18. [Effect of sublingual immunotherapy with Dermatophagoides Farinae on the expression of specific IgG4 in patients with allergic rhinitis in Hainan area]. Huang Q; Wei X; Lin X; Zheng J; Huang H Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 34(2):135-139. PubMed ID: 32086918 [No Abstract] [Full Text] [Related]
19. Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment. Martín-Muñoz MF; Pineda F; Muiños T; Fontan M; Nevot S; Bosque M; Jurado Palomo J; Torredemer A; Valdesoiro L; Martinez Cañavate AM; Pedemonte Marco C; Allergol Immunopathol (Madr); 2013; 41(1):4-10. PubMed ID: 22321665 [TBL] [Abstract][Full Text] [Related]
20. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]